{"symbol":"BMY","fiscalQuarter":"Q1-2023","reportDate":"2023-04-27","reportTime":"BMO","status":"reported","company":{"name":"Bristol-Myers Squibb Company","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BMY/earnings/Q1-2023","postBrief":{"headline":"Bristol Myers Squibb Beats on EPS, Stock Down 0.6%","keyNumbers":[{"metric":"EPS","actual":"$2.05","expected":"N/A","surprise":"+3.33%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management highlighted ongoing commitment to innovation and pipeline development.","They acknowledged challenges in the market but expressed confidence in long-term growth."],"summary":"Overall, management conveyed a sense of cautious optimism regarding the company's future. They emphasized their focus on pipeline advancements despite current market challenges."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Bristol Myers Squibb's earnings report showed a positive surprise in EPS, which reflects better-than-expected performance in that area. However, the stock reacted negatively, declining by 0.6%. This may indicate investor concerns about other aspects of the business, particularly since no revenue figures or guidance were provided.","metaDescription":"Bristol Myers Squibb (BMY) Q1 2023 earnings: EPS beat by 3.33%. Stock down 0.6%. Full breakdown."}}